Trailing-twelve-month (TTM) revenue is $6.85 Billion with a year-over-year growth of +39.58%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,606,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-28 |
| Q4 FY2025Period ended 2025-12-31 | $1,669,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-12 |
| Q1 FY2026Period ended 2026-03-31 | $1,901,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-27 |
| Q2 FY2026Period ended 2026-06-30 | $1,676,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-27 |
| TTM revenue | $6,852,000,000 |
Current P/S: $22,261,627,051 market capitalization ÷ $6,852,000,000 TTM revenue = 3.25x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.68B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| National Programs | $611M | $702M | $860M | $1.1B | N/A | N/A |
| Programs | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|
| CANADA | $24M | $35M | $40M | N/A |
| IRELAND | $38M | N/A | $48M | N/A |
| UNITED KINGDOM | $170M | $433M | $545M |
$6.85B
$6.85 Billion
+39.58%
vs. $4.91B a year ago (TTM)
+19.16%
5 Year compound annual growth rate
1 Year
+39.58%
3 Year
+20.01%
5 Year
+19.16%
10 Year
+14.93%
15 Year
+13.79%
20 Year
+11.10%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $5.96B | +$1.25B | +26.59% |
| 2024 | $4.71B | +$506.00M | +12.05% |
| 2023 | $4.20B | +$636.00M | +17.85% |
| 2022 | $3.56B | +$515.50M | +16.92% |
| 2021 | $3.05B | +$441.40M | +16.94% |
| 2020 |
TTM Growth
+39.58%
3-Year CAGR
+20.01%
5-Year CAGR
+19.16%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| $1.4B |
| N/A |
| Retail | $1.5B | $1.8B | $2.1B | $2.4B | $2.7B | $3.4B |
|---|
| Services | $174M | $179M | $172M | $163M | N/A | N/A |
|---|
| Specialty Distribution | N/A | N/A | N/A | N/A | N/A | $2.4B |
|---|
| Wholesale Brokerage | $353M | $403M | $453M | $541M | $616M | N/A |
|---|
| UNITED STATES | $3.3B | $3.7B | $4.1B | $5.1B |
|---|
| $2.61B |
| +$221.36M |
| +9.28% |
| 2019 | $2.38B | +$374.88M | +18.65% |
| 2018 | $2.01B | +$152.59M | +8.22% |
| 2017 | $1.86B | +$94.48M | +5.36% |
| 2016 | $1.76B | +$105.84M | +6.39% |
